Company · Biotechnology Research

Qualia Therapeutics

At Qualia Therapeutics, we’re pioneering the future of neurotechnology — combining real-time brain stimulation, AI, to restore the human mind after stroke, depression, and beyond. We are developing the world’s first closed-loop neurostimulation system that not only learns from the brain — but evolves with it. Our architecture is designed to integrate QML, empowering unprecedented pattern recognition and personalized therapy on a level traditional AI cannot match. Backed by medical partnerships and driven by a deep R&D pipeline, we don’t just treat the symptoms — we map the hidden architecture of consciousness.